Adult ICR/Sic or BALB/c mice developed hydrocephalus when attenuated herpes simplex virus type 1 (HSV-1) (strain Ska) was injected intracerebrally 2 to 4 weeks earlier and then after mice were challenged with the same virus or virulent HSV-1. Initial inoculation of the Ska strain elicited acute meningitis and ependymitis with transient mild hydrocephalus. Viral antigen was seen in the meninges and subependymal areas, and the virus was titrated during the acute phase of infection. After the second virus inoculation, more prominent inflammation was evoked in the same area, and the animals developed hydrocephalus, although viral antigen and infectious virus were hardly detected. When the mice were immunosuppressed with cyclophosphamide, they ceased to develop hydrocephalus. BALB/c nude mice did not show the same pathology, even though they were treated in the same way. When irradiated mice, which had been infected with the Ska strain intracerebrally 2 weeks earlier, received syngeneic immune spleen cells, they developed hydrocephalus. The T-cell nature of the effector cells was confirmed by the elimination of the pathology after treatment of the donor cells with anti-Thy-1.2 plus complement. No hydrocephalic mice were observed after treatment of the donor cells with anti-Lyt-1.2 plus complement, which gave further evidence of the T-cell nature of the effector cells as the Lyt-1+.2+ antigen-bearing subsets. Intervals between priming and challenge virus inoculation could be more than 18 months. The presence of purified HSV-1 envelope protein was feasible for the development of the hydrocephalic animals.
Herpes simplex virus type 1 (HSV-1) is now the most common cause of nonepidemic viral encephalitis in the world (6) . However, the pathogenesis of HSV-1 encephalitis in humans is poorly understood.
In 1978, a patient died because of HSV-1 encephalitis 5 months after onset of the disease. Pathological studies revealed deposition of the immune complex on the vascular wall and an unusual accumulation of lymphocytes in the perivascular area, which was accompanied by massive necrosis and loss of myelin (8) . These features suggest that the immunopathological processes occur during the development of the HSV-1 encephalitis, particularly in prolonged cases of the illness (K. Hayashi, K. Yanagi, and S. Takagi, J. Infect. Dis., in press).
We started to establish the animal model of the prolonged HSV-1 encephalitis using avirulent HSV-1 (strain Ska) which was attenuated by repeated zigzag passages of chorioallantoic membrane and suckling mouse brains to such an extent that even intracerebral (IC) inoculation into suckling mice failed to kill all of the mice (24) .
After repeated IC inoculation of the Ska strain, most of the mice developed a marked hydrocephalus without any clinical signs. Several viruses are known to produce hydrocephalus both in patients and experimental animals (1, 9, 13, 14, 17) . Primary damage of ependymal cells and periaqueductal edema with subsequent obstruction of the aqueduct have been the common pathological features of the disease. As a part of an inquiry into the influence of HSV-1 infection in the central nervous system (CNS), we report the morphological alterations and the possible mechanisms of HSV-1-induced hydrocephalus in mice. mice, and ICR/Slc mice were purchased from the Shizuoka Experimental Animal Farm (Hamamatsu, Shizuoka, Japan).
Immunofluorescence. Fluorescein isothiocyanate (FITC)-labeled anti-HSV-1 antibody was prepared from hyperimmune rabbit serum, and its specificity was confirmed by oneand two-step inhibition tests after its nonspecific reactivity was absorbed with acetone-treated mouse liver and brain powder (22) . Mouse brains were frozen in precooled nhexane at -80°C. Cryostat sections (thickness, 4 ,um) of the brains were made, and they were fixed with acetone for 10 min at room temperature. FITC-labeled anti-HSV-1 antibody was then flooded onto the sections and reacted at 37°C for 1 h or at 4°C overnight. After the sections were washed with phosphate-buffered saline, they were mounted onto microscope slides with buffered glycerol and observed under a fluorescence microscope (7) . FITC-labeled anti-mouse immunoglobulin M (IgM)(t), IgG(y), and IgA(ac) antibodies were purchased from Hoechst Japan Inc. Ltd., Tokyo, Japan.
Animal inoculation. Under light ether anesthesia, mice were inoculated with 0.025 ml of undiluted HSV-1 strain Ska into the right hemisphere of the brain. Some animals were inoculated with an equal volume of the supernatant of normal GMK cell lysate in the same locus. A stepped needle was used (the needle shaft was enlarged in the middle, thus preventing penetration beyond the enlarged section). Two weeks after the initial inoculation, the mice were again challenged IC with 0.025 ml of either HSV-1 strain Ska or strain CHR-3. The mice were then observed daily for clinical signs of infection.
Histopathology. Mice were sacrificed at given times after IC inoculation of the virus by ether anesthesia or cervical dislocation. Brains were removed and fixed in phosphatebuffered 10% Formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin (HE) or by the method of Kluver Immunoblotting analyses of the serum obtained from hydrocephalic mice. Lysates of HEp-2 cells which were infected with MacIntyre strain of HSV-1 and herpes simplex virus type 2 (HSV-2) (strain uw268) were first subjected to electrophoresis in a slab of sodium dodecyl sulfatepolyacrylamide gels by the method of Laemmli (16) .
The polypeptides were then transferred to a sheet of nitrocellulose ( anttenuated HSV-1 strain Ska or IC inoculation of strain Ska followed by challenge with HSV-1 strain CHR-3 at the same inoculation site (Table 1 ). Figure 1 shows three hydrocephalic and three normal brains.
The bilateral cerebral hemispheres of the hydrocephalic brains have indentations because of the collapse of the dilated ventricles. The interval between the primary and secondary IC inoculations of the virus was 2 weeks in most cases, and pathological changes were observed 2 weeks after the secondary inoculation. However, when the interval between the primary and secondary virus inoculations was extended to 3, 6, 12, and 18 months, 10 of 10, 12 of 13, 9 of 10, and 10 of 10 ICR/Slc mice, respectively, still developed hydrocephalus. Therefore, once the animals were sensitized locally, the effect lasted a considerable length of time, probably even for the entire lifetimes of the mice.
Animals that were given a primary inoculation intraperitoneally did not develop hydrocephalus even after IC challenge with the virulent HSV-1 strain CHR-3 (Table 1 ). This phenomenon indicates that local sensitization is essential for the development of the pathological changes.
Few of the animals that were injected once IC with either HSV-1 strain Ska or CHR-3 but that were not administered the challenge inoculation developed pathological changes, although mild encephalitis was seen in a few animals ( Table  1) .
Control mice that were inoculated with either CM or GMK cell lysate by the same schedule did not show any pathological changes (Table 1) .
Histopathology of the hydrocephalic brains. The dilation of the lateral ventricles was accompanied by rarefaction of paraventricular tissues, particularly of the callosal radiation (Fig. 2) . The ventricular wall was irregular and often devoid of ependymal lining cells, and proliferation of subependymal astrocytes was a prominent feature of the denuded areas (Fig. 3) . Mild mononuclear cell collection was occasionally encountered in perivascular spaces in the paraventricular parenchymal tissues (Fig. 4A) . The third ventricle was apparently obliterated in the mice with severe hydrocephalus. Mild mononuclear cell infiltration was also commonly seen in the subarachnoid space of hydrocephalic mice (Fig.  4B) .
Virus antigen was located by immunofluorescence staining during the acute phase of the initial viral inoculation.
Positive fluorescence of viral antigen was first detected 2 days postinfection (p.i.) in ependymal cells and in a part of the meninges (Fig. 5) . It then spread more widely to the adjacent brain tissues. neither strain Ska nor CHR-3 was titrated in the brain. Although no replication of infectious strain Ska or CHR-3 was demonstrated after secondary IC inoculation, positive fluorescence was seen in occasional ependymal and subependymal cells as described above. This fluorescence faded over the subsequent 3 to 4 days without noticeable involvement of an additional number of cells.
Serum neutralization antibody was first detected at 6 days post-primary infection and persisted with gradual increases of its activity up to 1:512 at 14 days p.i. when 50% reduction of the virus plaques from the control was taken as an endpoint. After challenge virus inoculation, the antibody FIG. 6 . Viral antigen localization 6 days after the primary IC inoculation of HSV-1 strain Ska. Closed circles indicate localization of HSV-1 antigen studied by direct immunofluorescence test 6 days after the primary IC inoculation of HSV-1 strain Ska. 1, Lateral ventricle; 2, cerebral cortex; 3, cerebellum.
titer was boosted precipitously and reached a maximum over 1:2,000 at 8 days post-secondary virus inoculation.
CSF free from contamination of the blood was obtained from the hydrocephalic brains. It contained a high titer of antiviral activity, although the class of immunoglobulin in the CSF was not determined because of the limited volume of the sample obtained for further analyses.
Inability to induce hydrocephalus in immunosuppressed mice and athymic BALB/c nude mice. To determine whether the immunopathological process was involved in the development of hydrocephalus, BALB/c mice were immunosuppressed by the administration of CY. They were weighed and CY (100 mg/kg of body weight) was given intraperitoneally as described above.
Mice that were treated with CY at the secondary virus inoculation did not develop hydrocephalus (Table 2 ). On the other hand, when the mice received CY at the pnmary virus inoculation and were not immunosuppressed at the secondary virus inoculation, they developed hydrocephalus, as did the untreated mice.
When BABL/c nude mice were inoculated IC with strain Ska and subsequently challenged IC with the same virus or strain CHR-3, they did not develop hydrocephalus (Table 3 ). All BALB/c nude mice that received IC the initially virulent strain CHR-3 died before it was time for them to receive the secondary virus inoculation.
These data strongly suggest the involvement of T-cellmediated immunopathology in the development of hydrocephalus.
Hydrocephalus induced after adoptive transfer of immune spleen cells. We next designed the adoptive transfer experiment to determine whether these processes could be transferred to the irradiated syngeneic mice by immune spleen cells. We also tried to define more precisely the T-cell subset of these processes by using monoclonal anti-T-cell subset antibodies. hydrocephali, although some of the animals showed slight hydrocephalic changes in their brains (Table 4) .
On the contrary, no hydrocephalic mice were observed when mice were administered normal syngeneic spleen cells. Histopathological examination of the hydrocephalic brains showed subarachnoidal and subependymal infiltrations of mononuclear cells and lymphocytes. Patchy destruction and detachment of ependymal cells was noted. As described above, these pathological features were similar to those seen in the hydrocephalic brains induced after repeated IC inoculation of strain Ska.
These features indicate strongly that the inflammatory reactions elicited after secondary virus challenge were more severe than those that were seen after primary virus infection. The inflammation occurred after the secondary virus challenge was mediated by immune T lymphocytes, thus resulting in obstructive hydrocephalus in these mice. a Two weeks after IC inoculation of strain Ska, BALB/c mice were irradiated with 400 rads with a Shimazu model SHT 250M-3 X-ray generator (Kyoto, Japan).
They were administered 1.5 x 108 immune spleen cells which had been treated with either anti-Thy-1.2 antibody plus complement or normal spleen cells via the tail vein. Two hours after adoptive transfer of the cells, recipient mice were inoculated IC with strain Ska. Two weeks after cell transfer, the mice were sacrificed and the brains were scored for hydrocephalus.
To determine whether these changes were mediated by Lyt-1+.2+-bearing T cells or the Lyt-2+.3+-bearing T cell subset, further transfer experiments were performed with BALB/c nude mice as recipients.
As described previously, nude mice did not develop hydrocephalus even after repeated challenge of strain Ska.
When these mice were administered syngeneic immune spleen cells which were depleted of Lyt-2+.3+ cells by treatment with anti-Lyt-2.2 antibody plus complement, they developed hydrocephalus, whereas recipient mice that were administered Lyt-1+.2+ cell-depleted immune spleen cells did not develop hydrocephalus appreciably (Table 5) .
Thus, we conclude that the inflammatory processes that lead to the final hydrocephalic pathology are dependent on the recruitment of the immune Lyt 1+.2+-bearing T-cell subsets into the crucial loci.
Antigenic requirements for the development of hydrocephalus. We next studied the antigenic requirement for the induction of the pathological changes.
Mice that were primed IC with strain Ska and then challenged with UV-inactivated virus or the purified envelope protein of HSV-1 elicited inflammatory reactions at the local site and developed hydrocephalus (Table 6 ). On the other hand, those mice that were inoculated with bovine serum albumin in place of UV-inactivated virus or the virus envelope protein did not develop hydrocephalus.
In the next step, serum obtained from the hydrocephalic mouse was analyzed by the Western blotting (immunoblotting) method (Fig. 8) . It was shown that the serum obtained from a hydrocephalic mouse which had been treated by regular, repeated IC virus inoculations of the Ska strain showed two bands at an approximate molecular weight of 130,000 (130K), a broad band at 65K to 83K and sharp bands at 58K, 48K, and 40K (Fig. 8, lane 2) . The serum had weak cross-reactivity to HSV-2 antigen (Fig. 8,  lane 3) .
The neutralizing antibody titer of this serum against HSV-1 was 1:1,024. Thus, it was suggested that at least some of the antigenic molecules that contributed to the immunopathology of these mice were a constituent of the HSV-1 envelope proteins, capsid proteins, or both.
DISCUSSION
This paper describes for the first time HSV-1-induced hydrocephalus in experimental animals.
The immunopathological nature of the disease process was analyzed, and we conclude that the Lyt-1+.2+-bearing T-cell subset that recognized one or more viral envelope proteins was at least partly responsible for this unique pathology.
When the virus was inoculated IC, virus particles were forced back along the needle tract due to the increase of intracranial pressure, thus flooding the entire subarachnoid space, the perivascular spaces, the ventricles, and the central canal of the spinal cord (12, 19) . Accordingly, viral antigen localization after the initial virus inoculation was primarily on the meninges, choroid plexus, and ependymal lining cells, which was followed by the spread to the ventricular walls and subependymal parenchyma. This initial distribution of the virus determined the patterns of the subsequent pathological changes, because avirulent strain Ska did not spread widely to the underlying brain cell populations, although multiple cycles of infectious virus production occurred. This localization of infection was similar but wider than those of the mumps, parainfluenza, and influenza virus infections, which shows the selective vulnerability of ependymal cells for the virus multiplications (10, 13, 14) .
Our findings show that Lyt-1+.2+-bearing T cells are the main effector for the pathological changes.
It is known that in CNS inflammatory processes, CSF, meningeal exudate, parenchymal infiltrate, and perivascular cuffing are different in each cell population (20) . Thus, it is conceivable that on secondary virus inoculation, antigen- around it; however, the pathognomonic significance of it is not clear at present, since hydrocephalus was produced in specific Lyt-1+.2+-bearing cells proliferated locally or remice by adoptive transfer of immune T cells, and in these cruited from the circulation because they recognized virally cases the immune complex was not detected even in sensitized target cells resulted in granular ependymitis, hydrocepahlic brains. choroiditis, and meningeal cell exudation, accompanied by
The clinical implications of our results are as follows. subependymal inflammation, and finally in the obstructive Hydrocephalic mice did not show any clinical abnormalities. hydrocephalus (11, 13) . However, it might also be possible
Once the mice were sensitized locally, the effect was obthat these cells recognized the modified host components served for almost their entire lives, and immunopathological and reacted with them to produce true autoimmunity. Furchanges were produced on encounter with another antigenic ther analyses are now under way to elucidate these probstimulation. HSV-1 reactivation, which is frequently seen lems. HSV-1 antigen was not detected in mouse brains at the around oral mucosa or lips, might also occur in the CNS; and not only recurrent encephalitis (15, 18) 
